Duke Accepts Potti Resignation; Retraction Process Initiated with Nature Medicine

Anil Potti, MD, has voluntarily resigned from his positions as associate professor of medicine at Duke University School of Medicine and at the university's Institute for Genome Sciences & Policy. Dr. Potti's resignation is effective immediately.

In addition, Dr. Potti's collaborator, Joseph Nevins, PhD, has initiated a process intended to lead to a retraction request regarding a paper previously published in Nature Medicine.

This process has been initiated due to concerns about the reproducibility of reported predictors, and their possible effect on the overall conclusions in this paper. Other papers published based on this science are currently being reviewed for any concerns.

The three clinical trials based on this science, for which new enrollment was suspended in mid-July, have been closed.

Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.